天益医疗
(301097)
| 流通市值：13.53亿 | | | 总市值：27.89亿 |
| 流通股本：3959.04万 | | | 总股本：8160.94万 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 530,880,401.73 | 338,262,037.04 | 163,867,248.73 | 575,755,706.89 |
| 营业收入 | 530,880,401.73 | 338,262,037.04 | 163,867,248.73 | 575,755,706.89 |
| 二、营业总成本 | 501,767,762.1 | 331,733,313.67 | 152,555,298.22 | 545,671,644.66 |
| 营业成本 | 280,238,958.04 | 180,009,728.52 | 85,333,685.23 | 328,328,844.48 |
| 税金及附加 | 5,601,121.23 | 3,805,730.96 | 2,003,451.65 | 8,007,653.77 |
| 销售费用 | 25,668,728.38 | 16,086,309.11 | 7,211,127.07 | 32,531,467.42 |
| 管理费用 | 126,676,220 | 82,274,810.57 | 36,137,773.08 | 107,822,182.62 |
| 研发费用 | 38,533,997.31 | 26,481,362.17 | 12,044,709.54 | 56,925,854.91 |
| 财务费用 | 25,048,737.14 | 23,075,372.34 | 9,824,551.65 | 12,055,641.46 |
| 其中:利息费用 | 14,421,262.59 | 8,629,177.93 | 4,505,159.06 | 13,387,835.53 |
| 其中:利息收入 | 7,258,736.27 | 4,845,377.65 | 2,491,545.18 | 15,047,073.28 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | -2,084,929.36 | 2,248,597.16 | -1,221,541.57 | 2,836,638.32 |
| 加:投资收益 | -7,421,596.65 | -17,425,378.79 | -8,204,747.55 | -25,133,196.19 |
| 资产处置收益 | 138,099.31 | 41,421.5 | -3,375.63 | 2,531.17 |
| 资产减值损失(新) | -2,061,068.05 | -2,042,340.87 | -18,726.75 | -8,977,087.25 |
| 信用减值损失(新) | 2,724,913.66 | 3,131,573.36 | 2,687,468.45 | -5,895,456.59 |
| 其他收益 | 10,292,580.18 | 9,430,596.07 | 6,646,838.42 | 6,159,547.75 |
| 四、营业利润 | 30,700,638.72 | 1,913,191.8 | 11,197,865.88 | -922,960.56 |
| 加:营业外收入 | 3,884.86 | 30.47 | 0.68 | 14,388.87 |
| 减:营业外支出 | 579,752.76 | 557,093.6 | 13,830.09 | 9,871,247.94 |
| 五、利润总额 | 30,124,770.82 | 1,356,128.67 | 11,184,036.47 | -10,779,819.63 |
| 减:所得税费用 | -14,364,956.55 | -14,761,593.45 | 1,889,283.92 | 5,440,602.93 |
| 六、净利润 | 44,489,727.37 | 16,117,722.12 | 9,294,752.55 | -16,220,422.56 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 44,489,727.37 | 16,117,722.12 | 9,294,752.55 | -16,222,422.16 |
| 终止经营净利润 | - | - | - | 1,999.6 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 44,489,727.37 | 16,117,722.12 | 9,294,752.55 | -16,220,422.56 |
| 少数股东损益 | - | - | - | 0 |
| 扣除非经常损益后的净利润 | 42,557,684.49 | 11,407,013.54 | 8,703,168.43 | -17,352,884.32 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.67 | 0.27 | 0.16 | -0.28 |
| (二)稀释每股收益 | 0.67 | 0.27 | 0.16 | -0.28 |
| 八、其他综合收益 | -23,043,482.57 | -18,057,322.41 | -1,015,981.82 | 4,411,878.64 |
| 归属于母公司股东的其他综合收益 | -23,043,482.57 | -18,057,322.41 | -1,015,981.82 | 4,411,878.64 |
| 九、综合收益总额 | 21,446,244.8 | -1,939,600.29 | 8,278,770.73 | -11,808,543.92 |
| 归属于母公司股东的综合收益总额 | 21,446,244.8 | -1,939,600.29 | 8,278,770.73 | -11,808,543.92 |
| 公告日期 | 2026-10-26 | 2026-08-21 | 2026-04-23 | 2026-04-23 |
| 审计意见(境内) | | | | 标准无保留意见 |